Home/Filings/4/0001415889-24-021089
4//SEC Filing

Jagpal Sukhi 4

Accession 0001415889-24-021089

CIK 0001382101other

Filed

Aug 11, 8:00 PM ET

Accepted

Aug 12, 4:40 PM ET

Size

8.1 KB

Accession

0001415889-24-021089

Insider Transaction Report

Form 4
Period: 2024-08-08
Jagpal Sukhi
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-08-08+28,95928,959 total
    Exercise: $3.22Exp: 2034-08-08Common Stock (28,959 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-08-08+35,00035,000 total
    Exercise: $3.22Exp: 2034-08-08Common Stock (35,000 underlying)
Footnotes (2)
  • [F1]The option vests as to 2.778% of the total award monthly, beginning on September 8, 2024, with 100% of the award being vested and exercisable on August 8, 2027, subject to the reporting person's provision of service to the issuer on each vesting date.
  • [F2]The option vests as to 10.07% of the total award monthly beginning on September 8, 2024 through May 8, 2025, and 9.38% shall vest on June 6, 2025, with 100% of the award being vested and exercisable on the date of the issuer's 2025 annual meeting of its stockholders, subject to the reporting person's provision of service to the issuer on each vesting date.

Issuer

SUTRO BIOPHARMA, INC.

CIK 0001382101

Entity typeother

Related Parties

1
  • filerCIK 0001554591

Filing Metadata

Form type
4
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 4:40 PM ET
Size
8.1 KB